Evelo Biosciences to Present at BioCentury NewsMakers Conference

CAMBRIDGE, Mass., Sept. 6, 2016 /PRNewswire/ -- Evelo Biosciences, the pioneering immuno-microbiome company, developing therapeutics for cancer, autoimmune and inflammatory diseases, today announced that Simba Gill, Ph.D., President and CEO, will present at BioCentury's 23^rd Annual NewsMakers in the Biotech Industry Conference. The presentation will take place on Friday, September 9, 2016 at 1:30p EDT in Presentation Room 402/403. The conference is being held at the Millennium Broadway Hotel & Conference Center in New York, NY.

About Evelo Biosciences

Founded in 2014, Evelo Biosciences has established the pioneering therapeutics discovery and development platform based on the human immuno-microbiome, the inter-connected metasystem comprising the human immune system and the human microbiome. Evelo is developing onco-microbials for the treatment of cancer and immuno-microbials for the treatment of autoimmune and inflammatory diseases. The company is translating its insights into the immuno-microbiome into a range of product candidates, which are being advanced toward first human testing in 2017.

For more information, please visit www.evelobio.com.

Logo - http://photos.prnewswire.com/prnh/20160328/348603LOGO 

SOURCE Evelo Biosciences

Related Links

http://www.evelobio.com